Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia - Test2 - elhamkhani - TriplyDB

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

http://www.wikidata.org/entity/Q24646206

about

Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia Computational neuropsychiatry - schizophrenia as a cognitive brain network disorder GABAergic interneuron origin of schizophrenia pathophysiology.Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: implications for the treatment of negative symptoms i Autism-associated neuroligin-3 mutations commonly disrupt tonic endocannabinoid signaling Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls Neurophysiological and computational principles of cortical rhythms in cognition Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia Common circuit defect of excitatory-inhibitory balance in mouse models of autism.The dysconnection hypothesis (2016)From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia A Comprehensive Review of the (1)H-MRS Metabolite Spectrum in Autism Spectrum Disorder Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology Anti-N-methyl-d-aspartate receptor encephalitis: review of clinical presentation, diagnosis and treatment Converging levels of analysis on a genomic hotspot for psychosis: insights from 22q11.2 deletion syndrome Synaptic plasticity, neural circuits, and the emerging role of altered short-term information processing in schizophrenia.Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.Following the genes: a framework for animal modeling of psychiatric disorders Toward developmental models of psychiatric disorders in zebrafish GABA abnormalities in schizophrenia: a methodological review of in vivo studies The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signaling Redefining the classification of AMPA-selective ionotropic glutamate receptors Mutation of Semaphorin-6A disrupts limbic and cortical connectivity and models neurodevelopmental psychopathology Knockout of NMDA-receptors from parvalbumin interneurons sensitizes to schizophrenia-related deficits induced by MK-801 Novel human ᴅ-amino acid oxidase inhibitors stabilize an active-site lid-open conformation Excitation-inhibition discoordination in rodent models of mental disorders.Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review The impact of NMDA receptor hypofunction on GABAergic neurons in the pathophysiology of schizophrenia Glutamate receptor ion channels: structure, regulation, and function Neuropathological and Reelin deficiencies in the hippocampal formation of rats exposed to MAM; differences and similarities with schizophrenia Blinded prospective evaluation of computer-based mechanistic schizophrenia disease model for predicting drug response Phencyclidine Disrupts the Auditory Steady State Response in Rats Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins Neocortical excitation/inhibition balance in information processing and social dysfunction Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia.Investigating Cortical Inhibition in First-Degree Relatives and Probands in Schizophrenia The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.

P2860

Q21262976-ACF60DFF-6695-44E0-9D9B-B82D6D2E8F5F Q22241226-EF6423DC-5E3E-455C-92D5-63397B3F3EFE Q24597790-F53687E1-9AD8-4293-AB5C-7E8AEA0C5272 Q24612550-BE61CCBA-E899-4905-8E31-05657162DA9B Q24621061-204B3222-8219-453F-A0E8-18155E619C00 Q24621853-F599255E-D7FC-4980-9A84-1F12761AFE69 Q24623659-408F1E44-9E8B-4D47-B9EA-77200DE1B378 Q24630528-EA0D2D6B-B64E-4A1C-BCC7-5A13649D7BB2 Q24631189-08E3AE9A-C9F5-4EC7-97CD-998F3DE8A1B7 Q24649621-E4592B28-FFCD-45B4-9B21-C06A439E63E1 Q26269924-C7EA6F99-25EC-40B3-A7F5-780F93566607 Q26741916-DE3F12AC-D36D-4B77-89FD-06555D1EA807 Q26744755-F066AE20-2583-4E1F-BBFD-23000D7A83A0 Q26751201-ADD33435-03DB-4C23-8E38-66656AA2B5C2 Q26782867-69D68815-8133-4F91-9884-443DECC10B8F Q26801897-22D0C72D-78A3-44B5-BCE4-6D3B21DA66D2 Q26824150-E657CAD1-6138-4C71-954F-A83B56FF246A Q26829347-9C388CCA-48EB-4A02-B802-146413BCE018 Q26830533-2E63AB17-D334-46CA-8714-88823744E1F5 Q26830603-924E5125-CE4C-44F5-A6F7-7BDEC9283E7F Q26830848-07CE8EF5-B66C-47C2-8D4D-B48659F118AD Q26864125-E9852F4A-3B2E-4CA4-A2FB-5B3016D477AB Q27023087-70493E0C-7BE5-42CF-B44E-80E732EA21AC Q27023967-5D190B93-CFB3-4C63-AE74-343D91CF7BFF Q27026601-ED051B71-12A7-4642-99A9-FCA6843A1971 Q27315950-8099B985-8FA8-49E2-91CF-C0332CF8B252 Q27338525-1F7A97BE-1E1A-4CBF-9C9A-A8A16267F0D2 Q27684575-DE64FEE6-CF4B-48D9-8B6C-65E80C37439B Q27692087-3CFE62A4-A8B3-44DF-831E-DC7EC456E5C1 Q28070122-4F00C913-A5F5-4A0A-95CB-B5CAD59ACBAF Q28081110-096A8D1A-2201-4C84-A32A-33D1B03AFD41 Q28290774-9D85D503-DE24-49D1-B808-75A1B61D3A3E Q28473742-BBF2D13A-76BB-47D2-B8F8-4A8DDABCB357 Q28484377-F762853C-2302-4A6E-9F74-F348CC06C908 Q28547137-8BEBF7CF-0915-43F4-B014-44584B12F9F4 Q28585023-6788F780-B5EF-4B2B-8039-3D177358122E Q29616196-9A68B476-70B4-4765-8D82-0EEF7646DA90 Q30355619-81E25226-68A6-4A5C-9C00-9AB0B299B0DB Q30358965-65BCE26C-F356-4624-B2C5-F7D1D835FE58 Q30362017-976E8E44-AE6A-496F-9543-57844D323BA0

P2860

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

http://www.wikidata.org/entity/Q24646206

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

name

Circuit-based framework for un ...... interactions in schizophrenia

@ast

Circuit-based framework for un ...... interactions in schizophrenia

@en

Circuit-based framework for un ...... interactions in schizophrenia

@nl

type

label

Circuit-based framework for un ...... interactions in schizophrenia

@ast

Circuit-based framework for un ...... interactions in schizophrenia

@en

Circuit-based framework for un ...... interactions in schizophrenia

@nl

prefLabel

Circuit-based framework for un ...... interactions in schizophrenia

@ast

Circuit-based framework for un ...... interactions in schizophrenia

@en

Circuit-based framework for un ...... interactions in schizophrenia

@nl

P1433

Q24646206-10691B0F-0DAB-46AB-9962-46FB8B3526BB

P1476

Q24646206-61D1C5DE-27F2-482B-8F6C-87FB9E236270

P2093

Q24646206-079C665B-B7D1-484E-AA34-C7F8707D9886

Q24646206-122C316A-0A71-4B44-972B-95EAA8260FF6

Q24646206-32258299-BB03-4F7E-AD0E-ECD14815B1CB

Q24646206-83930ED8-3183-47AD-A781-38CF9A45679D

Q24646206-B359D3C3-5812-4AAD-8BCE-138A2AEBBB8C

P2860

Q24646206-01645EB5-3C4D-450E-A04F-FD246F8E72FA

Q24646206-0266C546-32B4-4994-B942-0CAA91D1C965

Q24646206-029B821B-5583-4333-A85E-3ED22E32EAE2

Q24646206-02F1D0DD-CB5A-4F71-A0C3-EC11411AC5F8

Q24646206-02FD3CA2-1745-4C6A-BC05-61063CD17635

Q24646206-0484AA2F-5D6C-4687-9FCF-29481FA16918

Q24646206-06C76EAE-F009-4C84-8AB2-35CCC0002370

Q24646206-0736FE52-B8DE-4021-AE78-3F2C25034001

Q24646206-08ADADEB-B814-466D-91D7-9CD39D288BAF

Q24646206-0A0E221F-B2B3-4C4D-AB15-D7156B1B8FF5

P304

Q24646206-26ECE1A5-29C2-40BC-A323-716D63B2F022

P31

Q24646206-F1B0BFB8-139F-4325-BBC4-3E9F5E130981

P3181

Q24646206-B6A7D374-0A7D-4ECD-8431-53B2F97D8851

P356

Q24646206-808A0A6B-9A02-4C7A-9BEC-47A80E646016

P407

Q24646206-BF4FCCB8-AE80-4571-9C80-EDF40A11298B

P433

Q24646206-53765D08-681F-4E6B-B9CE-B0B15959B3D5

P478

Q24646206-A71D5F7E-16F3-4203-B00C-BEDEC70376FE

P50

Q24646206-6F76FA63-356F-4C6B-BE31-EEAAEC56D290

Q24646206-B28F88E7-02FC-4904-9ABA-22514BE60540

P577

Q24646206-3531130A-6437-4D64-870D-6B501232CABC

P5875

Q24646206-06385A04-7952-4083-8005-26942B37D2E3

P698

Q24646206-D6EEF976-834F-4C0D-9EC7-E85831FDAC5D

P921

Q24646206-6CE4E5A7-69EC-4D17-8C7F-C848868199A2

Q24646206-C0843781-AB1A-41F9-B265-4D7E3C6515F2

P932

Q24646206-A459CBC2-865C-4412-8BBF-A545A5A78CB6

P3181

P356

J.TINS.2008.02.005

P1433

Trends in Neurosciences

P1476

Circuit-based framework for un ...... interactions in schizophrenia

@en

P2093

Francine M Benes

http://www.w3.org/2001/XMLSchema#string

John E Lisman

http://www.w3.org/2001/XMLSchema#string

Joseph T Coyle

http://www.w3.org/2001/XMLSchema#string

Robert W Green

http://www.w3.org/2001/XMLSchema#string

Stephan Heckers

http://www.w3.org/2001/XMLSchema#string

P2860

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia

Serine racemase binds to PICK1: potential relevance to schizophrenia

Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia

Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series

Early-stage visual processing and cortical amplification deficits in schizophrenia.

Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars

GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia

P304

234-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

416100

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.TINS.2008.02.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Anthony A. Grace

Daniel C Javitt

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5456489

http://www.w3.org/2001/XMLSchema#string

P698

18395805

http://www.w3.org/2001/XMLSchema#string

P921

neurotransmitter

P932

2680493

http://www.w3.org/2001/XMLSchema#string